MedTrace Logo

Effect of Atorvastatin on Glycemic Control in Prediabetic Patients

NCT02470455 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2015-08-17

No results posted yet for this study

Summary

The study was conducted to find out any possible effect of Atorvastatin on glycemic parameters in prediabetic patients.

Conditions

  • Prediabetic State

Interventions

DRUG

Atorvastatin

Some patients were receiving 20 mg of Atorvastatin wheras others were on a higher dose of 40-80mg daily. Patients were taking statins for either dyslipidemia, or primary or secondary prevention of cardiovascular disease.

Sponsors & Collaborators

  • Shri Ramachandra Bhanj Medical College

    lead OTHER

Principal Investigators

  • TRUPTI R SWAIN, MD · SCB Medical College, Cuttack, Odisha

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • India

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02470455 on ClinicalTrials.gov